Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- CARGO Therapeutics, Inc.
- AnaptysBio, Inc.
Updated Jul 16, 2026
Orwin John A has filed 7 SEC Form 4 filings across 3 companies in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | TRAX | First Tracks Biotherapeutics, Inc. | M — Option exercise | 6.0K | $0.00 | |
| 2026-06-17 | ANAB | ANAPTYSBIO, INC | M — Option exercise | 6.0K | $0.00 | |
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2025-09-15 | ANAB | ANAPTYSBIO, INC | M — Option exercise | 1.3K | $0.00 |
Orwin John A is a corporate insider — currently tracked as Insider of First Tracks Biotherapeutics, Inc. (TRAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
7 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Orwin John A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.